Skip to main content
Serge Jabbour, MD, Endocrinology, Philadelphia, PA, Thomas Jefferson University Hospitals

SergeA.JabbourMD

Endocrinology Philadelphia, PA

Diabetes, Lipid Metabolism

Director, Division of Endocrinology, Professor of Medicine, Thomas Jefferson University

Dr. Jabbour is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Jabbour's full profile

Already have an account?

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 1999
  • Cooper Medical School of Rowan University/Cooper University Hospital
    Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 1994 - 1997
  • St Joseph's University Medical School
    St Joseph's University Medical SchoolClass of 1993
  • La Sagesse College
    La Sagesse CollegeBachelors, Experimental Sciences, 1983 - 1986

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - 2023
  • NJ State Medical License
    NJ State Medical License 1999 - 2003
  • PA State Medical License
    PA State Medical License 1997 - 2024
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Philadelphia Magazine Castle Connolly, 2011-2015
  • Top Doctor in Endocrinology South Jersey Magazine, 2013
  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Safety and Efficacy of Exenatide Once Weekly plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients with Type 2 Diabetes Inadequately Contro...  
    Serge Jabbour, MD, Diabetes Care
  • Dapagliflozin in Type 2 Diabetes: Effectiveness Across the Spectrum of Disease and Over Time  
    Parikh S, Wilding J, Jabbour SA, Hardy E, IJCP (International Journal of Clinical Practice), 1/1/2015
  • Incidence and Severity of Pancreatogenic Diabetes after Pancreatic Resection  
    Burkhart RA, Gerber SM, Tholey RM, Lamb KM, Somasundaram A, McIntyre CA, Fradkin EC, Ashok AP, Felte RF, Mehta JM, Rosato EL, Lavu H, Jabbour SA, Yeo CJ, and Winter JM, Journal of Gastrointestinal Surgery, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Robust Dose-dependent Glucose Lowering and Body Weight (BW) Reductions with the Novel Oral Formulation of Semaglutide in Patients with early Type 2 Diabetes (T2D)
    Jabbour S, Pieber T, Rosenstock J, Hartoft-Nielsen ML, Højbjerg Hansen OK, Davies M, The Endocrine Society, Boston, MA, 1/1/2016
  • Efficacy, patient-reported outcomes and safety of insulin degludec 200 U/mL and insulin glargine in patients with type 2 diabetes (T2D) requiring high-dose insulin
    Warren M, Chaykin L, Jabbour S, Sheikh-Ali M, Thim Hansen C, Rasmussen SR, Norwood P, ADA (American Diabetes Association); 23nd World Diabetes Congress, Boston, MA, 2015; Vancouver, Canada, 2015, 1/1/2015
  • Incidence of Radioiodine-induced Gastritis and the Dosage of I-131 Ablation for Differentiated Thyroid Cancer: Results of a Multi-year Analysis
    Intenzo C, Jabbour SA, Miller J, Kim S, Furlong K, Ahmed I, SNMMI (Society of Nuclear Medicine and Molecular Aging) Annual Meeting, Baltimore, MD, 1/1/2015
  • Join now to see all

Lectures

  • Guideline-Based Approach to Manage T2DM: Place of SGLT2-Inhibitors 
    Lucknow, India - 1/31/2015
  • Improving the Metabolic State in T2DM Patients & Associated Risks 
    Lucknow, India - 1/29/2015
  • Glucocorticoids and HPA Axis Suppression 
    Philadelphia, PA - 1/24/2015
  • Join now to see all

Other

Press Mentions

  • Portland Doctor to Receive National Kidney Foundation’s Highest Honor (National Kidney Foundation Inc)
    Portland Doctor to Receive National Kidney Foundation’s Highest Honor (National Kidney Foundation Inc)April 5th, 2016
  • Approaching Insulin Intensification in Diabetes Care
    Approaching Insulin Intensification in Diabetes CareFebruary 15th, 2018
  • Celebrating the New and Improved Bicoastal Clinical Endocrinology Update!
    Celebrating the New and Improved Bicoastal Clinical Endocrinology Update!July 26th, 2018
  • Join now to see all

Hospital Affiliations